Ten thousand steps is one of the best-known health targets in the world. The useful part is that it gives people a simple goal. The misleading part is treating the number as if human biology suddenly changes at step 10,000.
A large 2025 systematic review makes the picture more encouraging: people do not need to reach 10,000 before benefits appear. And twin research adds another layer — how much people move in everyday life is not only about willpower or discipline.
Quick answer
Is 7,000 steps now the “correct” number?
No single step count is optimal for everyone. Around 7,000 steps per day is a practical evidence-based target for many adults, especially compared with very low activity, while benefits can begin below that and may continue above it for some outcomes.
Key takeaways
- A 2025 meta-analysis synthesised 57 studies from 35 cohorts and found meaningful health associations well below 10,000 daily steps.
- Compared with 2,000 steps per day, 7,000 was associated with substantially lower risks across several outcomes, but these are population associations rather than guaranteed individual effects.
- For several outcomes the dose-response curves began to flatten around 5,000–7,000 steps, while risk continued to decline beyond 7,000 for others.
- Objective twin studies suggest that differences in activity and sedentary behaviour have a heritable component.
- Genes can influence the starting point; they do not dictate how many steps a person will take tomorrow.
Why 7,000 became interesting
The Lancet Public Health review included 57 studies from 35 cohorts. In dose-response meta-analyses, 7,000 steps per day compared with 2,000 was associated with 47% lower all-cause mortality, 25% lower cardiovascular-disease incidence, 47% lower cardiovascular mortality, 14% lower type 2 diabetes risk, 38% lower dementia risk, 22% lower depressive-symptom risk and 28% lower fall risk.
These figures do not mean that walking exactly 7,000 steps causes those precise reductions for every individual. Most of the underlying evidence is observational, so differences in health, behaviour and socioeconomic circumstances can still influence the associations.
More than 7,000 is not “wasted”
For all-cause mortality, cardiovascular-disease incidence, dementia and falls, the review found nonlinear relationships with inflection points around 5,000–7,000 steps. For several other outcomes, the association was more linear. Across most outcomes, risks generally continued to fall with each additional 1,000 steps up to the highest analysable categories.
So 10,000 can still be an excellent target if it is realistic and enjoyable. The important correction is that people who currently walk very little do not need to wait for 10,000 before their increased activity becomes meaningful.
What twin research asks instead
Twin studies have not established a special step target for identical or fraternal twins. Their contribution is different: they help researchers ask why some people are naturally more active than others.
In 1,654 twins who wore combined movement and heart-rate sensors, genetic factors contributed to variation in several objectively measured activity traits and sedentary behaviour. Heritability here is a population statistic — it is not a “motivation gene” and not a limit on behaviour change.
MOBILETWIN: when an ordinary association changed inside identical pairs
The MOBILETWIN study followed 774 older Finnish twins with accelerometers. People without reported mobility limitations averaged 7,074 steps per day; those with some limitations averaged 4,437 and those with severe limitations 2,637.
At the individual level, more steps were clearly associated with fewer mobility limitations. The same pattern remained within 144 dizygotic pairs but was not seen within 117 monozygotic pairs. That does not prove that genes cause the association; it suggests that genetic or other shared familial factors may contribute to both activity and mobility.
A useful target is one that moves you forward
For someone walking 2,000 steps a day, moving toward 4,000 or 5,000 can be a meaningful change. Around 7,000 is a practical benchmark supported by the 2025 evidence synthesis. Someone who comfortably walks 10,000 or 12,000 has no research-based reason to reduce activity merely because a curve flattens for one outcome.
Age, disability, disease, occupational activity, training volume and the intensity of movement all matter. Step count is useful because it is simple — not because it captures every dimension of health.
TwinPare perspective: genes influence the starting line, not tomorrow’s step count
The most interesting question may not be “which number wins?” but why the same target feels easy for one person and demanding for another. Twin research shows that activity behaviour is partly shaped by inherited differences and family background.
Population research simultaneously shows that changing behaviour matters. The two ideas are compatible: biology influences tendencies, while environment, opportunity, health, habits and personal choices influence what happens next.
Source notes
The sources have been verified and editorially reviewed for this article. The limitations below show which level of conclusion the sources support.
- [ding-2025] Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis Ding Ding et al.. The Lancet Public Health, 2025. Evidence type: Systematic review of 57 studies from 35 cohorts; dose-response meta-analysis Limitation: Associations are observational and can be affected by residual confounding. The authors found meaningful benefits below 10,000 steps and described 7,000 as a realistic target for many adults, not a universal biological threshold. PubMed DOI
- [denhoed-2013] Heritability of objectively assessed daily physical activity and sedentary behavior Marcel den Hoed et al.. American Journal of Clinical Nutrition, 2013. Evidence type: Objective activity monitoring in 1,654 twins Limitation: The study estimated population-level genetic contributions to variation in objectively measured activity and sedentary behaviour; it does not imply a fixed genetic activity level for an individual. PubMed PMC DOI
- [pullinen-2024] Association Between Accelerometer-Measured Physical Activity and Mobility Limitations in Twins Pia Pullinen et al.. Journal of Aging and Physical Activity, 2024. Evidence type: Cross-sectional MOBILETWIN study of 774 older Finnish twins Limitation: Published online in 2024. At the individual level, step counts differed strongly by mobility limitation; the association persisted within dizygotic pairs but not within monozygotic pairs, suggesting shared familial or genetic influences may contribute. PubMed DOI
Editorial source review
This section shows how the article's key factual claims are linked to the source.
Phrasings that require caution
- Step-count evidence is largely observational and does not guarantee an individual risk reduction.
- There is no universal optimal daily step target for every age, health condition or level of disability.
- Heritability of activity is a population estimate and should never be interpreted as genetic destiny.
| ID | Claim | Source support | Caution |
|---|